Legal status · Canada
Is Orforglipron legal in Canada?
No. Orforglipron is not approved for any medical use in Canada; its classification is "Not yet approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Orforglipron in Canada at a glance
| Classification | Not yet approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada; investigational |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Orforglipron profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Orforglipron is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Orforglipron is
An investigational once-daily oral GLP-1 receptor agonist that is a small molecule rather than a peptide, studied for obesity and diabetes.
Orforglipron is an oral GLP-1 receptor agonist (FDA-approved April 2026 as Foundayo) notable for being a small-molecule pill rather than an injected peptide, which could make GLP-1 therapy easier to scale. Phase 2 and Phase 3 trials have reported meaningful weight loss and glucose lowering.
Mechanism: Activates the GLP-1 receptor as an orally available small molecule, reducing appetite and improving glucose-dependent insulin secretion.
Regulatory history: FDA-approved April 1, 2026 as Foundayo for chronic weight management (boxed thyroid C-cell warning)
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Orforglipron at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Orforglipron in other countries
United States
Approved medicineFDA-approved (Foundayo, chronic weight management), prescription only
Is Orforglipron legal in the United States?United Kingdom
InvestigationalNot yet licensed
Is Orforglipron legal in the United Kingdom?Australia
InvestigationalNot yet registered
Is Orforglipron legal in Australia?Frequently asked questions
Is Orforglipron legal in Canada?
No. Orforglipron is not approved for any medical use in Canada; its classification is "Not yet approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy Orforglipron in Canada?
No approved product exists to buy. In Canada Orforglipron is classified as "Not yet approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Orforglipron Health Canada approved?
No. In Canada Orforglipron is classified as "Not yet approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: FDA-approved April 1, 2026 as Foundayo for chronic weight management (boxed thyroid C-cell warning). Evidence level: Moderate.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Orforglipron live on its compound profile.
Orforglipron profileThis page is general information about the regulatory status of Orforglipron in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.